Informa Markets India managing director Yogesh Mudras expressed bullish sentiments regarding India's fast-growing pharmaceuticals sector. Photo Credit: Yogesh Mudras/LinkedIn
Exhibition organiser Informa Markets in India signalled the country's
business events recovery with the return of the PharmaLytica Expo,
which took place from 1-3 June 2022 at the Bombay Exhibition Centre,
Mumbai.
Returning in full offline format, the global pharmaceuticals trade
show and conference featured 30 conference speakers and over 300 brands
as exhibitors, eager to network and conduct business face-to-face with
an estimated 7,000 trade visitors.
At the same time, while the tradeshow and conference has embraced the
return of in-person attendance, PharmaLytica has nonetheless offered a
suite of innovative digital solutions as either an option or to
complement its offline format. These include a wholesalers digital
marketplace, a virtual exhibition, webinars, and customised product
symposia.
According to Informa Markets India managing director Yogesh Mudras,
India's fast-growing pharmaceuticals industry is set to become a US$130
billion industry by 2030. He added that India's government has alloted
Rs862 billion (approximately US$11.1 billion) for the sector in its
2022-2023 annual budget.
“We are delighted to bring back the 8th edition of the PharmaLytica
Expo in its full offline format, bringing the entire ecosystem of the
industry and stakeholders under one roof. This aligns with the PM’s
vision to 'Ideate in India, Innovate in India, Make in India and Make
for the World,'” Mudras said.